Quantum dot and Cy5.5 labeled nanoparticles to investigate lipoprotein biointeractions via Förster resonance energy transfer

Nano Letters

Volumn 10, Issue 12, 2010, Pages 5131-5138

  Skajaa, Torjus ^a,c   Zhao, Yiming ^d   Van Den Heuvel, Dave J ^d   Gerritsen, Hans C ^d   Cormode, David P ^a   Koole, Rolf ^d   Van Schooneveld, Matti M ^d   Post, Jan Andries ^e   Fisher, Edward A ^f   Fayad, Zahi A ^a   De Mello Donega, Celso ^d   Meijerink, Andries ^d   Mulder, Willem J M ^a,b  

^a Translational and Molecular Imaging Institute   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d UTRECHT UNIVERSITY   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apolipoprotein A I; F rster resonance energy transfer (FRET); lipid exchange; lipoproteins; live cell imaging; Quantum dots

Indexed keywords

APOLIPOPROTEIN A-I; APOLIPOPROTEINS; CARDIO-VASCULAR DISEASE; CELL INTERACTION; LIPID EXCHANGE; LIPOPROTEINS; LIVE-CELL IMAGING; MACROPHAGE CELLS; QUANTUM DOT; QUANTUM DOTS; RESONANCE ENERGY TRANSFER;

ASSOCIATION REACTIONS; COATINGS; ENERGY TRANSFER; LIPIDS; NANOPARTICLES; OPTICAL WAVEGUIDES; RESONANCE;

SEMICONDUCTOR QUANTUM DOTS;

LIPOPROTEIN; NANOPARTICLE; QUANTUM DOT;

ARTICLE; FLUORESCENCE RESONANCE ENERGY TRANSFER; METABOLISM; PROTEIN BINDING;

FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPOPROTEINS; NANOPARTICLES; PROTEIN BINDING; QUANTUM DOTS;

EID: 78650123329     PISSN: 15306984     EISSN: 15306992     Source Type: Journal    
DOI: 10.1021/nl1037903     Document Type: Article

References (49)

1. Cormode, D. P.; Skajaa, T.; Fayad, Z. A.; Mulder, W. J. Nanotechnology in medical imaging: probe design and applications Arterioscler., Thromb., Vasc. Biol. 2009, 29, 992-1000
2. Cormode, D. P. Nanocrystal core high-density lipoproteins: A multimodal molecular imaging contrast agent platform Nano Lett. 2008, 8, 3715-3723
3. Dubertret, B. In vivo imaging of quantum dots encapsulated in phospholipid micelles Science 2002, 298, 1759-1762
4. Mulder, W. J. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe Nano Lett. 2006, 6, 1-6
5. Mulder, W. J.; Strijkers, G. J.; van Tilborg, G. A.; Griffioen, A. W.; Nicolay, K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging NMR Biomed. 2006, 19, 142-164
6. Medintz, I. L.; Mattoussi, H.; Clapp, A. R. Potential clinical applications of quantum dots Int. J. Nanomed. 2008, 3, 151-167
7. Bruns, O. T.; Ittrich, H.; Peldschus, K.; Kaul, M. G.; Tromsdorf, U. I.; Lauterwasser, J.; Nikolic, M. S.; Mollwitz, B.; Merkel, M.; Bigall, N. C.; Sapra, S.; Reimer, R.; Hohenberg, H.; Weller, H.; Eychmüller, A.; Adam, G.; Beisiegel, U.; Heeren, J. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat. Nanotechnol. 2009, 4 ((3)) 193-201. (PubMed PMID: 19265850).
8. Mulder, W. J. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots Angiogenesis 2009, 12, 17-24
9. Prabaharan, M.; Grailer, J. J.; Pilla, S.; Steeber, D. A.; Gong, S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery Biomaterials 2009, 30, 6065-6075
10. Nitin, N.; LaConte, L. E.; Zurkiya, O.; Hu, X.; Bao, G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent J. Biol. Inorg. Chem. 2004, 9, 706-712
11. Lu, J. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging Biomaterials 2009, 30, 2919-2928
12. Mulder, W. J. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging Acc. Chem. Res. 2009, 42, 904-914
13. Nichols, A. V.; Krauss, R. M.; Musliner, T. A. Nondenaturing polyacrylamide gradient gel electrophoresis Method Enzymol. 1986, 128, 417-431
14. Tall, A. R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J. Intern. Med. 2008, 263, 256-273
15. Davidson, W. S. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein J. Biol. Chem. 1994, 269, 22975-22982
16. Gordon, D. J.; Rifkind, B. M. High-density lipoprotein-the clinical implications of recent studies New Engl. J. Med. 1989, 321, 1311-1316
17. Stampfer, M. J.; Sacks, F. M.; Salvini, S.; Willett, W. C.; Hennekens, C. H. A propective study of cholesterol, apolipoproteins, and the risk of myocardial infarction N. Engl. J. Med. 1991, 325, 373-381
18. Lusis, A. J. Atherosclerosis Nature 2000, 407, 233-241
19. Gill, R. Probing biocatalytic transformations with CdSe-ZnS QDs J. Am. Chem. Soc. 2006, 128, 15376-15377
20. Gill, R.; Willner, I.; Shweky, I.; Banin, U. Fluorescence resonance energy transfer in CdSe/ZnS-DNA conjugates: probing hybridization and DNA cleavage J. Phys. Chem. B 2005, 109, 23715-23719
21. Liu, W. Compact biocompatible quantum dots functionalized for cellular imaging J. Am. Chem. Soc. 2008, 130, 1274-1284
22. Clapp, A. R. Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors J. Am. Chem. Soc. 2004, 126, 301-310
23. Gill, R.; Zayats, M.; Willner, I. Semiconductor quantum dots for bioanalysis Angew. Chem., Int. Ed. 2008, 47, 7602-7625
24. Koole, R. Magnetic quantum dots for multimodal imaging Nanomed. Nanobiotechnol. 2009, 1, 475-491
25. Medintz, I. L. Self-assembled nanoscale biosensors based on quantum dot FRET donors Nat. Mater. 2003, 2, 630-638
26. Medintz, I. L. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates Nat. Mater. 2006, 5, 581-589
27. Jiang, G. Cascaded FRET in conjugated polymer/quantum dot/dye-labeled DNA complexes for DNA hybridization detection ACS Nano 2009, 3, 4127-4131
28. Fernandez-Arguelles, M. T. Synthesis and characterization of polymer-coated quantum dots with integrated acceptor dyes as FRET-based nanoprobes Nano Lett. 2007, 7, 2613-2617
29. Koole, R. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging Bioconjug. Chem. 2008, 19, 2471-2479
30. Ntziachristos, V.; Ripoll, J.; Wang, L. V.; Weissleder, R. Looking and listening to light: the evolution of whole-body photonic imaging Nat. Biotechnol. 2005, 23, 313-320
31. Choi, H. S. Renal clearance of quantum dots Nat. Biotechnol. 2007, 25, 1165-1170
32. Choi, H. S. Design considerations for tumour-targeted nanoparticles Nat. Nanotechnol. 2010, 5, 42-47
33. Wang, M.; Briggs, M. R. HDL: The Metabolism, Function, and Therapeutic Importance Chem. Rev. 2004, 104, 119-127
34. Mahley, R. W.; Innerarity, T. L.; Rall, S. C., Jr.; Weisgraber, K. H. Plasma lipoproteins: apolipoprotein structure and function J. Lipid Res. 1984, 25, 1277-1294
35. Rothblat, G. H. Cell cholesterol efflux: integration of old and new observations provides new insights J. Lipid Res. 1999, 40, 781-796
36. Jonas, A. Interaction of bovine serum high density lipoprotein with mixed vesicles of phosphatidylcholine and cholesterol J. Lipid Res. 1979, 20, 817-824
37. Vedhachalam, C. ABCA1-induced cell surface binding sites for apoA-I Arterioscler., Thromb., Vasc. Biol. 2007, 27, 1603-1609
38. Lu, R.; Arakawa, R.; Ito-Osumi, C.; Iwamoto, N.; Yokoyama, S. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation Arterioscler., Thromb., Vasc. Biol. 2008, 28, 1820-1824
39. Frank, P. G.; Marcel, Y. L. Apolipoprotein A-I: structure-function relationships J. Lipid Res. 2000, 41, 853-872
40. Tall, A. R.; Small, D. M.; Deckelbaum, R. J.; Shipley, G. G. Structure and thermodynamic properties of high density lipoprotein recombinants J. Biol. Chem. 1977, 252, 4701-4711
41. Pownall, H. J.; Massey, J. B.; Kusserow, S. K.; Gotto, A. M., Jr. Kinetics of lipid - protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines Biochemistry 1978, 17, 1183-1188
42. Frank, P. G.; Marcel, Y. L. Apolipoprotein A-I: structure-function relationships J. Lipid Res. 2000, 41, 853-872
43. Rye, K.-A.; Barter, P. J. Antiinflammatory actions of HDL: a new insight Arterioscler., Thromb., Vasc. Biol. 2008, 28, 1890-1891
44. Acton, S. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor Science 1996, 271, 518-520
45. Rodrigueza, W. V. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells J. Biol. Chem. 1999, 274, 20344-20350
46. van Tilborg, G. A. Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells Bioconjug. Chem. 2006, 17, 865-868
47. Lanza, G. M. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles Nanomedicine (London, U.K.) 2006, 1, 321-329
48. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discovery 2005, 4, 145-160
49. O'Reilly, R. K.; Hawker, C. J.; Wooley, K. L. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility Chem. Soc. Rev. 2006, 35, 1068-1083